Nyxoid. EMA: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 October 2026 

Nyxoid. EMA: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 October 2026 

(…)

The committee recommended changing the legal status of Nyxoid (naloxone) to make it available without a medical prescription. Nyxoid is a nasal spray used for emergency treatment in case of known or suspected overdose of opioid drugs, such as heroin or morphine. (EMA - European Medicines Agency, Amstradem, 16.10.2026)

https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-12-15-october-2026